System4 Technologies GmbH: Universal Therapy Device For COVI

System4 Technologies GmbH: Universal Therapy Device For COVID-19, COVID-19 Mutations, and Other Virus Variants Unveiled
Possible use in intensive care medicine and treatment of long COVID.
Planned large-scale study on universal use against coronaviruses and other RNA viruses.
BAD ZWISCHENAHN, GERMANY / ACCESSWIRE / April 21, 2021 / The life science company System4 Technologies GmbH has developed a new therapy device for the treatment of Covid patients.
The device, named PI-RNA, is designed to enable universal and fast deactivation of coronaviruses and influenza viruses, their mutations and new variants by means of
a special cold atmospheric plasma procedure. "The so-called CAP (Cold Atmospheric Plasma) - technology transfers electrostatically atmospheric anions, in high numbers and densities, into and around the body of the patient. This is achieved through a

Related Keywords

Hungary , Tim Stelter , Kostenloser Wertpapierhandel , Benjamin Seibt , Ilir Guslo , Fraunhofer Institute For Toxicology , Max Planck Institute , Cold Atmospheric Plasma , Managing Director , Fraunhofer Institute , System4 , Technologies , Mbh , Niversal , Therapy , Device , Covid , Mutations , Mother , Virus , Variants , Nveiled , பசி , ப்ரௌுந்ொபேர் நிறுவனம் க்கு நச்சுயியல் , குளிர் வளிமண்டலம் பிளாஸ்மா , நிர்வகித்தல் இயக்குனர் , ப்ரௌுந்ொபேர் நிறுவனம் , ம்ப் , விட் ,